IL2RA and acute myeloid leukemia: The results indicate that proliferating Tregs with an increased CD25 expression and low CD45RA, markers of an activated phenotype (14), are present in the bone marrow of AML patients and may therefore contribute to an immunosuppressive microenvironment.